在该公司于2013年5月3日向证交会提交的文件中,该公司董事会建议股东们投票批准修改公司2005年股权激励计划增发245万普通股,这个举动无疑会稀释...查看全文
阿虎41102011-12-21 16:41
2011-12-21以$8.49买入 $普罗基尼克斯制药(PGNX)$。2011年12月21日 投资银行&资产管理公司Needham上调其评级为买入,目标价位$10查看全文
$普罗基尼克斯制药(PGNX)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001193125-20-185879 Act: 34 Size: 10 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013681 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013671 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013672 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013673 Size: 17 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013674 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013675 Size: 13 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013676 Size: 9 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013677 Size: 8 KB 网页链接
$普罗基尼克斯制药(PGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013678 Size: 32 KB 网页链接